Efficacy of azimilide and dofetilide in the dog right atrial enlargement model of atrial flutter

Journal of Cardiovascular Electrophysiology

Volumn 12, Issue 9, 2001, Pages 1018-1024

  Restivo, Mark ^a   Hegazy, Maha ^a   El Hamami, Moustafa ^a   Yin, Hong ^a   Caref, Edward B ^a   Assadi, Mahshid A ^a   Brooks, Robert R ^b   El Sherif, Nabil ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

Animal model; Atrial arrhythmia; Azimilide; Canine; Class III antiarrhythmic agent; Dofetilide; Reentry; Right atrial enlargement

Indexed keywords

ANTIARRHYTHMIC AGENT; AZIMILIDE; DOFETILIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFICACY; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FLUTTER; HEART CONDUCTION; HEART MUSCLE REFRACTORY PERIOD; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; TRICUSPID VALVE;

EID: 0034848741     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2001.01018.x     Document Type: Article

References (30)

1. Atrial dispersion of refractoriness
2. Drug choices in the treatment of atrial fibrillation
3. Antiarrhythmic agents for atrial fibrillation: Focus on prolonging atrial repolarization
4. Mechanisms of action of class III agents and their clinical relevance
5. Drug treatment of atrial fibrillation in the managed care era
6. Effects of the novel antiarrhythmic agent azimilide on experimental atrial fibrillation and atrial electrophysiologic properties
7. Effects of azimilide dihydrochloride on circus movement atrial flutter in the canine sterile pericarditis model
8. Azimilide treatment of atrial fibrillation
9. Antiarrhythmic effects of azimilide in atrial fibrillation: Efficacy and dose-response
10. Pharmacology of azimilide dihydrochloride (NE-10064)
11. Use-dependent effects of the class III antiarrhythmic agent NE-10064 (azimilide) on cardiac repolarization: Block of delayed rectifier potassium and L-type calcium currents
12. Effects of class III drugs on atrial fibrillation
13. Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide compared to the class IA antiarrhythmic drug quinidine in experimental canine atrial flutter: Role of dispersion of refractoriness in antiarrhythmic efficacy
14. A unified functional/anatomic substrate for circus movement atrial flutter: Activation and refractory patterns in the canine right atrial enlargement model
15. Antiarrhythmic efficacy of azimilide dihydrochloride on functional circus movement atrial flutter in the canine right atrial enlargement modelo
16. Preferential prolongation of refractoriness in the lower right atrium by the class III agent dofetilide. Target for antiarrhythmic action in two models of functional circus movement atrial flutter
17. Circus movement atrial flutter in the canine sterile pericarditis model. Activation patterns during initiation, termination, and sustained reentry in vivo
18. Circus movement atrial flutter in canine sterile pericarditis model. Activation patterns during entrainment and termination of single-loop reentry in vivo
19. The effects on atrial electrophysiology and structure of surgically induced right atrial enlargement in dogs
20. Suppression of inducible ventricular arrhythmias by intravenous azimilide in dogs with previous myocardial infarction
21. Electropharmacology of dofetilide, a new class-III agent, in anaesthetised dogs
22. Antiarrhythmic efficacy of a new class III agent, UK-68,798, during chronic myocardial infarction: Evaluation using three-dimensional mapping
23. Ks) on canine atrial flutter
24. Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide in an experimental canine model of pacing-induced atrial fibrillation
25. Effects of dofetilide on electrical dispersion and arrhythmias in post-infarcted anesthetized dogs
26. Effects of dofetilide, a class III antiarrhythmic drug, on various ventricular arrhythmias in dogs
27. Downregulation of delayed rectifier K(+) currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes
28. Reentrant arrhythmias in the subacute infarction period. The proarrhythmic effect of flecainide acetate on functional reentrant circuits
29. Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation
30. Conduction left-to-right and right-to-left across the crista terminalis